Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$71.6M |
| 2 |
Pfizer
PFE
|
+$63M |
| 3 |
ExxonMobil
XOM
|
+$55.2M |
| 4 |
Coca-Cola
KO
|
+$53.3M |
| 5 |
Johnson Controls International
JCI
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$155M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$76.3M |
| 3 |
Gilead Sciences
GILD
|
+$60M |
| 4 |
Delta Air Lines
DAL
|
+$51.4M |
| 5 |
JPMorgan Chase
JPM
|
+$50.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.07% |
| 2 | Healthcare | 13.5% |
| 3 | Financials | 13.06% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
United Therapeutics
UTHR
$22.7B
| $15.1M | 0.02% |
128,131
+4,886
| +4% | +$587K |
|
|
UNIT
877
Uniti Group
UNIT
$2.28B
| $15.1M | 0.02% |
481,284
+102,872
| +27% | +$3.16M |
|
878
RenaissanceRe
RNR
$13.2B
| $15M | 0.02% |
125,194
+376
| +0.3% | +$44.3K |
|
|
AVNS
879
DELISTED
Avanos Medical
AVNS
| $15M | 0.02% |
432,898
+137,190
| +46% | +$4.81M |
|
880
Neurocrine Biosciences
NBIX
$16.8B
| $15M | 0.02% |
296,121
+41,545
| +16% | +$2.07M |
|
881
Nabors Industries
NBR
$1.33B
| $15M | 0.02% |
24,643
+220
| +0.9% | +$108K |
|
882
AXIS Capital
AXS
$7.43B
| $15M | 0.02% |
275,719
+10,775
| +4% | +$594K |
|
|
HZNP
883
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $15M | 0.02% |
825,108
+109,549
| +15% | +$2.14M |
|
884
Pebblebrook Hotel Trust
PEB
$2B
| $14.9M | 0.02% |
561,156
+56,509
| +11% | +$1.62M |
|
|
BRCD
885
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $14.9M | 0.02% |
1,616,343
-49,029
| -3% | -$457K |
|
|
AMTD
886
DELISTED
TD Ameritrade Holding Corp
AMTD
| $14.9M | 0.02% |
423,278
+5,673
| +1% | +$177K |
|
887
Guidewire Software
GWRE
$14.4B
| $14.8M | 0.02% |
247,466
+83,946
| +51% | +$5.17M |
|
888
Dick's Sporting Goods
DKS
$19.2B
| $14.8M | 0.02% |
261,457
-323
| -0.1% | -$17.8K |
|
889
Advanced Energy
AEIS
$12.6B
| $14.8M | 0.02% |
312,762
-9,073
| -3% | -$386K |
|
890
XPO
XPO
$23.5B
| $14.7M | 0.02% |
1,162,942
+257,158
| +28% | +$2.91M |
|
|
TSRO
891
DELISTED
TESARO, Inc.
TSRO
| $14.7M | 0.02% |
146,990
+39,947
| +37% | +$3.73M |
|
|
MDR
892
DELISTED
McDermott International
MDR
| $14.7M | 0.02% |
978,243
+97,834
| +11% | +$1.46M |
|
|
JOY
893
DELISTED
Joy Global Inc
JOY
| $14.7M | 0.02% |
528,571
-51,165
| -9% | -$1.36M |
|
894
Assured Guaranty
AGO
$3.36B
| $14.7M | 0.02% |
528,076
+38,396
| +8% | +$1.04M |
|
|
PEI
895
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $14.6M | 0.02% |
42,307
+3,556
| +9% | +$1.27M |
|
896
Sabre
SABR
$835M
| $14.6M | 0.02% |
518,214
+19,351
| +4% | +$540K |
|
|
ALE
897
DELISTED
Allete
ALE
| $14.6M | 0.02% |
244,648
+22,257
| +10% | +$1.37M |
|
898
Jones Lang LaSalle
JLL
$16.4B
| $14.6M | 0.02% |
128,061
+8,524
| +7% | +$951K |
|
899
Moog Inc Class A
MOG.A
$13B
| $14.6M | 0.02% |
244,702
+32,270
| +15% | +$1.84M |
|
900
Avient
AVNT
$4.19B
| $14.6M | 0.02% |
430,463
-138,084
| -24% | -$4.78M |
|
Similar funds
Charles Schwab's Q3 2016 Portfolio in Review
As of Q3 2016, Charles Schwab held 3,130 positions worth $85.1B, up 6.4% from $80B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 3.8%. Charles Schwab opened 24 new positions and exited 95, leaving the 3,130-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q3 2016 buy was Fortive: 1,338,065 shares worth $43M.
- Charles Schwab added most to Charter Communications in Q3 2016, an estimated $71.6M increase.
- Charles Schwab's biggest Q3 2016 reduction was CR Bard Inc., cutting an estimated $76.3M.
- Charles Schwab fully exited EMC CORPORATION in Q3 2016, selling an estimated $155M.
- Charles Schwab's ten largest holdings make up 14% of its $85.1B portfolio in Q3 2016.
- Charles Schwab opened 24 new positions and closed 95 in Q3 2016.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $85.1B.
Based on Charles Schwab's 13F filing for Q3 2016, filed 14 Nov 2016.